HIV funding cuts threaten decades of progress, experts warn

Experts warn that recent cuts to HIV funding threaten to reverse decades of progress in the global fight against AIDS. The warnings come amid reports of reduced international donor contributions, including potential cuts from major funders such as the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria. The funding shortfall could disrupt access to antiretroviral therapy for millions of people, increase mother-to-child transmission, and undermine prevention efforts, including pre-exposure prophylaxis (PrEP). At the recent World AIDS Conference 2026, activists demonstrated with chants of 'Shame!' to protest the funding gaps. Organizations like Médecins Sans Frontières (Doctors Without Borders) are calling for cheaper generic versions of the HIV prevention drug to ensure broader access. National AIDS councils, such as the German AIDS-Hilfe, have also raised alarms about potential budget cuts at the local level, as seen in Hamburg. The cumulative effect of these cuts could lead to a resurgence of HIV infections and AIDS-related deaths, particularly in low- and middle-income countries that rely heavily on international aid.

Global Impact

The funding cuts have significant economic and social implications, particularly for sub-Saharan Africa, which bears the highest burden of HIV. Reduced access to treatment could lead to higher mortality and morbidity, undermining human capital and economic output in affected countries.